| abstract |
An in vitro method for designing personalized therapy for a subject having breast cancer comprising: i) quantifying the level of expression, copy number, amplification or gain of the c-MAF gene in a sample from said subject and ii) comparing the expression level, copy number, amplification or gain obtained in i) with a reference value, where if the expression level, copy number, amplification or gain is not increased with respect to said reference value, then said subject is amenable to receiving a therapy selected from the group consisting of: clodronate, ibandronate, and zoledronic acid. |